Proshares將於本週在TACIT SEC批准後本週推出三個XRP跟踪的ETF

交易所交易資金（ETF）發行人Proshares將在本週簽署美國證券交易委員會（SEC）批准後，本週推出了三種XRP跟踪產品。

In a swift move following the U.S. Securities and Exchange Commission’s (SEC) tacit approval, exchange-traded funds (ETF) issuer ProShares will introduce three XRP-tracked products this week.

在美國證券交易委員會（SEC）默認批准之後，迅速採取行動，交易所交易資金（ETF）發行人Proshares將於本週推出三種XRP跟踪產品。

Its approvals for an Ultra XRP ETF (2x leverage), a Short XRP ETF and an Ultra Short XRP ETF (-2x leverage) come after the SEC had shot down several attempts to launch a Bitcoin ETF in the past seven years.

它對Ultra XRP ETF（2倍槓桿），短XRP ETF和超短XRP ETF（-2X槓桿）的批准是在過去七年中銷量發射比特幣ETF之後的。

The regulator also approved several XRP spot ETF applications, setting a May 22 deadline for Grayscale's filing of the SEC Chair's decision.

監管機構還批准了幾個XRP Spot ETF應用程序，為5月22日的截止日期為Grayscale提交了SEC主席的決定。

ProShares’ approvals come after Monero integrators began preparations for U.S. ETF launches last month, while the applications were initially made in December.

Proshares的批准是在Monero Integrators上個月開始為US ETF推出的準備工作之後，而申請最初是在12月進行的。

The filings come a few weeks after Teucrium's 2x XRP ETF started trading earlier this month, marking the first such product in the U.S. It saw over $5 million in trading volumes on the first day, making it the firm's "most successful" launch to date.

這些文件是在Teucrium的2x XRP ETF本月初開始交易幾週後，標誌著美國的第一個產品在第一天就看到了超過500萬美元的交易量，這使其成為迄今為止的“最成功”的發布。

Earlier this month, CME Group also added XRP futures to its largest derivatives exchange in the U.S. for launch next month, alongside BTC, ETH and SOL products.

本月初，CME Group還將XRP期貨與BTC，ETH和SOL Products一起在美國最大的衍生品交易所添加了XRP期貨。

The move comes after closely related company Ripple's long-standing court battle against the SEC over the token was fully concluded in March, clearing extensive regulatory headwinds for the tokens.

此舉是在3月完全結束的，緊密相關的公司Ripple與SEC在代幣上與SEC在代幣上進行的長期法庭之戰，從而消除了代幣的廣泛監管逆風。